Diquertin tablets 0.02 (Tablets) Instructions for Use

ATC Code

V03AX (Other therapeutic agents)

Active Substance

Dihydroquercetin (Grouping name)

Clinical-Pharmacological Group

Antioxidant drug

Pharmacotherapeutic Group

Antioxidant agent

Pharmacological Action

A plant-derived bioflavonoid obtained from the wood of the Siberian larch (Larix sibirica Ledeb.) or the Dahurian larch (L. dahurica Turcz.). It has angioprotective, antioxidant, detoxifying, hepatoprotective (antitoxic), radioprotective, and anti-edema effects; it stimulates the regeneration processes of the gastric mucosa.

It prevents the peroxidation of lipids in cell membranes, protects vessel walls from damage, reduces swelling during inflammation, and possesses hypolipidemic and diuretic activity.

In patients with acute pneumonia, it effectively reduces the high intensity of lipid peroxidation by days 10-14 and contributes to the normalization of alpha-tocopherol levels in plasma; it has anti-inflammatory, detoxifying, and immunomodulatory effects, reduces the severity of bronchial obstruction, accelerates the clinical and radiological resolution of pneumonia, and promotes the restoration of capillary resistance.

In patients with exacerbation of COPD, it contributes to a faster disappearance of catarrhal phenomena and bronchial edema, and a more complete restoration of external respiration parameters.

In patients with bronchial asthma in the exacerbation stage, positive dynamics of functional indicators of external respiration are observed, a reduction in the frequency of attacks and the amount of sputum, and a significant improvement in bronchial patency indicators.

In patients with unstable angina (as part of complex therapy), a reduction and disappearance of signs of myocardial ischemia and restoration of heart rhythm are noted.

Indications

Use for the treatment of the following conditions.

• Respiratory tract diseases: acute pneumonia, chronic obstructive pulmonary disease (COPD), and bronchial asthma (infectious-allergic form during the exacerbation stage).
• Ischemic heart disease (IHD): unstable angina.
• Cardiac arrhythmias: supraventricular arrhythmias, as part of combination therapy.

ICD codes

Dosage Regimen

Administer orally. The dosage depends on the stage of the disease.

During the acute period of illness, take 40-60 mg four times daily.

During the convalescence period, take 20 mg four times daily.

The standard course of treatment is 3 to 4 weeks. Repeated courses of therapy are possible as determined by a physician.

Adverse Reactions

Adverse reactions are generally infrequent and mild in nature.

Allergic reactions are possible. Discontinue use and consult a physician if any signs of hypersensitivity appear.

Drug Interactions

Formal drug interaction studies have not been conducted.

Due to its antioxidant and membrane-stabilizing properties, it may potentially enhance the effects of other cardiovascular and anti-inflammatory medications.

Inform your physician about all concomitant medications you are taking.

Contraindications

Do not use under the following conditions.

• Hypersensitivity to dihydroquercetin or any other component of the formulation.

Overdose

Cases of overdose have not been reported.

In the event of suspected overdose and the appearance of severe adverse reactions, discontinue the medication immediately.

Initiate symptomatic and supportive treatment as no specific antidote exists.

Use in Pregnancy and Lactation

No data available.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.